KCM
GH icon

Karp Capital Management’s Guardant Health GH Stock Holding History

Karp Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21,290
Closed -$1.48M – 95
2020
Q1 		$1.48M Buy
+21,290
New +$1.63M 0.49% 59

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Karp Capital Management's GH Position: Q2 2020 in Review

Karp Capital Management sold out of Guardant Health (GH) in Q2 2020, closing a stake of 21,290 shares — an estimated $1.48M sold.

Karp Capital Management first reported a position in GH in Q1 2020 and held it in 1 quarter. The position peaked at $1.48M in Q1 2020. 325 funds tracked by Wall St. Rank hold GH as of Q2 2020.

  • Karp Capital Management reported no remaining Guardant Health position as of Q2 2020 after selling out during the quarter.
  • Karp Capital Management sold 21,290 Guardant Health shares in Q2 2020, an estimated $1.48M.
  • Karp Capital Management first reported a position in Guardant Health in Q1 2020 and held it in 1 quarter.
  • Karp Capital Management's Guardant Health position peaked at $1.48M in Q1 2020.
  • 325 funds tracked by Wall St. Rank held Guardant Health as of Q2 2020.

Based on Karp Capital Management's 13F filing for Q2 2020, filed 4 Aug 2020.